Christopher Milazzo

Christopher Milazzo currently serves as Sr. Director of Clinical Practice Liaisons at Madrigal Pharmaceuticals, a position held since July 2024. Prior experience includes roles at AbbVie as National Director for Field Medical in Migraine and Botox Therapeutic, alongside leadership positions at Allergan as Director of Regional Medical Science Liaisons for Migraine and Urology. Milazzo's earlier career features significant roles such as President of BioImpact Services, Director of Commercial Science at Pacific Edge, Director of Drug Development at Orico, and various managerial positions at Covance and Primedica Laboratories. Milazzo holds a BS in Animal Sciences from Cornell University and a PhD in Medical and Surgical Sciences from the University of Otago, specializing in orthopaedics and tissue engineering.